OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Nephrology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
A UMOD variant with intermediate effects	991
Mentorship in the lives of scholars	958
Inhibitory effects of oestradiol on ferroptosis may underlie sex differences in AKI	576
The changing landscape of kidney health and disease in Africa	545
Designing acute kidney injury clinical trials	534
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease	469
Treatment of chronic kidney disease in older populations	432
Disaster preparedness for patients with kidney disease	381
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	357
Uropathogen and host responses in pyelonephritis	328
Urine as a source of biomarkers and biological knowledge in chronic kidney disease	293
Engineered CAR macrophages target kidney inflammation	277
Vaccination in patients with kidney failure: lessons from COVID-19	262
The GLP-1 receptor agonist revolution comes to nephrology	260
Role of the gut microbiota in the pathogenesis of IgA nephropathy	242
Making advance care planning easier for adults with kidney disease and their clinicians	236
CD93 and endothelial cells as therapeutic targets in podocytopathies	224
Kidney health within the broader non-communicable disease agenda	204
A single-cell atlas of DKD treatment responses	203
Genetic determinants of urine and plasma metabolite levels	196
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	189
Consideration of sex differences is necessary to achieve health equity	185
Strategic rebalancing of kidney-related investments is key to implementing the WHO kidney health resolution	169
Roles of sensory receptors in non-sensory organs: the kidney and beyond	165
Beyond state borders: transforming dialysis care for undocumented immigrants	163

Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	161
The continued odyssey to unravel the secrets of kidney inflammation	157
Complosome — the intracellular complement system	144
Phosphate sensing via PTC glycolysis	134
Bringing Pride to nephrology	133
Reducing preventable acute kidney injury in a hospital setting	124
Mutational signatures of ccRCC vary between geographical regions	114
The impact of social determinants of health on acute kidney injury	111
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	110
Informing clinical decision making during a pandemic — a call for better preparedness	106
The effects of sex hormone therapy on kidney function	104
Clonal haematopoiesis and AKI	101
20 years of Nature Reviews Nephrology	100
Increasing diversity and inclusion in nephrology clinical trials	96
Interferon blockade in lupus: effects on antiviral immunity	96
Aquaporin water channels: roles beyond renal water handling	94
The roles of hyaluronan in kidney development, physiology and disease	94
Menopause and chronic kidney disease	91
Design of a renal-sparing antifungal	89
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	87
Benefits of actin cytoskeleton stabilization	87
Treatment of SLE with anti-CD19 CAR-T cells	85
Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure	84
Heat and health inequity: acting on determinants of health to promote heat justice	81
Tertiary lymphoid organs contribute to kidney allograft rejection	81
Environmental stewardship and health systems: Indigenous-centred reflections	80
Salt substitution: opportunities and challenges for nephrology	80
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	74
Identification of erythropoietin-producing cells	74
From fat to filter: the effect of adipose tissue-derived signals on kidney function	73
The role of complement in kidney disease	72
Long-term health outcomes associated with hydration status	72
Neutrophils and NETs in kidney disease	71
Pathological mechanisms of kidney disease in ageing	70
The evolving landscape of immune-mediated glomerular diseases	69
Reaping the rewards of mechanistic discovery in glomerular disease	69
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	69
A golden year of innovative kidney disease therapeutics	68
A label-free optical analysis for molecular nephrology	62
MSC therapy for diabetic kidney disease and nephrotic syndrome	61
Atmospheric stressors and kidney diseases	60
Network medicine: an approach to complex kidney disease phenotypes	60
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	58
A pathway of osmotic stress-induced necroptosis	58
Consequence of microvascular inflammation in transplantation	57
Combination therapy for kidney disease in people with diabetes mellitus	57
Ketogenic diet benefits in critically ill patients with sepsis	55
Transcatheter mitral valve repair in patients with CKD	54
Consequences of famine and malnourishment on kidney health	53
Long COVID and the kidney	50

The cilia mechanosensation debate gets (bio)physical	50
GalNAc-T14-associated defects in B cell homing in IgA nephropathy	50
Quality-oriented diet therapy for chronic kidney disease	49
PDGFRβ CAR T cells improve fibrosis in kidney disease models	47
Role of the cGAS–STING pathway in systemic and organ-specific diseases	44
Community power building to reduce inequities in access to health care	44
Continuing kidney care in conflicts	43
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	43
Mechanism of B cell survival in lupus nephritis	42
Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors	42
Dietary protection of proximal tubules in diabetes	42
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia	42
Gene therapy in a model of nephrotic syndrome	41
Multifaceted innovations needed to advance transplant nephrology	40
Mannose as a driver of γδ T cell kidney infiltration	40
The kidney is a novel target of metformin	40
Born too soon: lifelong kidney risks and the importance of early intervention	39
Targeting IL-1Ra to attenuate fungal infection	38
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	38
Generation of self-assembling kidney progenitor assembloids	37
IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxis	36
Steps forward in the treatment of IgA nephropathy	36
Epithelial cell states associated with kidney and allograft injury	36
Chronic cardiovascular–kidney disorder: a new conceptual framework	35
A guide to gene–disease relationships in nephrology	35
The genetics of hypertension	34
Metabolic alterations in hereditary and sporadic renal cell carcinoma	34
Role of necroptosis in kidney health and disease	33
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	33
Derivation of collecting duct organoids	32
Fasting induces structural and functional changes in the peritoneal membrane	32
Strategies to achieve gender equity in nephrology	31
A guide to uraemic toxicity	30
Insights into the impact of pregnancy on kidney disease	30
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	30
Renal nerves in physiology, pathophysiology and interoception	28
Acute kidney injury in patients with burns	28
Leveraging data as a patient–scientist: frustrations and opportunities	27
The increasing burden of mild and moderate anaemia in CKD	27
From big data to smart decisions: artificial intelligence in kidney risk assessment	26
Green nephrology: from evidence to action	26
The immunology of sepsis: translating new insights into clinical practice	26
Author Correction: Therapeutic advances in COVID-19	26
The impact of intrauterine growth restriction and prematurity on nephron endowment	26
Fibroblast activation and heterogeneity in fibrotic disease	25
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	25
Insulin resistance and hyperinsulinaemia in kidney disease: mechanisms and metabolic effects	25
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	24
Crosstalk between glomeruli and tubules	23
CD38 — a new target in renal immune disease	23
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	22
Digital determinants of health: opportunities and risks amidst health inequities	22